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The aim of this study was to construct a mammary gland specific expression plasmid pIN and validate 
its function in expressing goat insulin-like growth factor 1 (IGF-1). The backbone plasmid pBC1 
contained goat β-casein 5′ arm and β-casein 3′ arm, to target mammary gland-specific gene expression. 
First, the igf-1 gene was cloned from liver tissue harvested from a Saanen dairy goat and inserted 
downstream of the β-casein 5' arm. Then the neo gene was amplified from plasmid pCDNA3.1 and 
placed downstream of the β-casein 3' arm as a positive selection marker. In order to analyze the 
bioactivity of plasmid pIN, it was transfected into the Bcap-37 cell line and injected into goat mammary 
gland. Western-blotting and quantitative polymerase chain reaction (PCR) results confirmed the 
expression of IGF-1 protein and mRNA in transfected Bcap-37 cells. Further studies (RIA) demonstrated 
that the expression of IGF-1 protein in transfected group was much higher than that in control group (p 
< 0.05). In vivo results showed that the expression of IGF-1 in injected group was significantly higher 
than that in control group. All our results provide evidence that pIN is a mammary gland specific 
expression plasmids that can target expression of IGF-1 to mammary tissue, with the goal of increasing 
milk production. 
 





Improving milk production of goat by transgenic animal 
technology is a promising strategy, but requires selecting 
an appropriate gene for increased expression. Mammary 
gland development and milk production are affected by 
many hormone genes (Plante et al., 2011), such as 
growth hormone, prolactin (PRL), progesterone, estrogen 
and insulin-like growth factor 1 (IGF-1) (Kaskous et al., 
2003). IGF-1 is a hormone similar to insulin in molecular 
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and insulin receptor. In addition to insulin-like effect, IGF- 
1 can regulate cell growth and development. After binding 
to IGF-1R, it initiates intracellular signaling: activating 
AKT signal pathway, a stimulator of cell growth and 
proliferation. Also IGF-1 has growth-promoting effects on 
almost every cell. The deficiency of IGF-1 will directly 
lead to non-development of mammary gland (Ruan et 
al.,1999). 
IGF-1 plays a role in lactation mainly in two aspects: on 
one hand, IGF-1 increases the milk production of animals 
in unit time. Prosser et al. (1994) proved that arterial 
infusion of IGF-1 into mammary gland increased milk 
yield by 9% in goat. On the other hand, IGF-1 enhances 
sustainability of lactation in lactating animals. Hadsell et 
al. (2002) demonstrated that IGF-1 slowed the apoptotic 
loss of mammary epithelial cells during the recession 
phase of lactation, which implied that IGF-1 possessed a 
potent inhibitor of programmed cell death. The ability of 
modifying mammary gland function through transgenic 





production of milk. Previous research had suggested 
strategies for changing milk composition to reduce the 
energetic cost of milk production and to reduce the 
microbial load in milk. The perceived utility of mammary 
gland may, in part, account for the considerable attention 
that had been focused on investigating transgene 
expression in mammary glands. Most studies are 
designed to address both basic and applied aspects of 
expressing additional protein in mammary gland, while 
the bulk of research literature are focused on biomedical 
rather than agricultural applications. 
The aim of our research was to construct a mammary 
gland specific expression plasmid pIN and validate its 
function in Bcap-37 cell line and goat mammary gland. 
Mammary-specific promoter such as casein (Lee et al., 
1996; Zinovieva et al., 1998), whey protein (Hadsell et al., 
1996)
 
and lactalbumin (Su and Cheng, 2004) were wildly 
used in transgene animal. We used β-casein to initiate 
the expression of IGF-1. Our research laid a solid 
foundation for producing IGF-1 genetically modified goat 
with increasing milk production. 
 
 
MATERIALS AND METHODS 
 
Materials and reagents 
 
Liver and mammary gland were harvested from Saanen dairy 
goats. Plasmid pBC1 was generously donated by Professor Cheng 
of Yangzhou University. Plasmid pCDNA3.1 and Bcap-37 cell line 
were provided by Professor Wang of Nanjing Agricultural University. 
Plasmid pBluescript II SK (+) was purchased from Takara (Japan). 
Escherichia coli JM 109 strain was kept in our laboratory. Mouse 




Construction of vector pIN 
 
The amplification of igf-1 and neo gene 
 
The full-length of goat igf-1 gene was 960 bp (Gene Bank ID: 
D11378), while the open reading frame (ORF) region was 483 bp. 
Total RNA was extracted from liver of Saanen dairy goat with Trizol 
reagent. Reverse Transcriptase M-MLV was used to synthesize 
cDNA. Parameters for PCR were as follows: 94°C for 5 min; 94°C, 
30 s; 57°C, 30 s; 72°C, 50 s; 30 cycles; 72°C, 10 min; 10°C. After 
amplification, 25 µL PCR products were run on a 1.5% agarose gel 




The amplification of neo gene  
 
The full-length of the neo gene is 1521 bp and contains promoter 
and poly (a) tail. Using the plasmid pcDNA3.1 as a template, PCR 
amplification was performed with PrimeSTAR® HS DNA 
polymerase. PCR primers used for this study were listed in Table 1. 
The PCR products of IGF-1 and neo gene were isolated and 
purified. Purified DNA fragments were linked to plasmid pMD19-T. 
Recombinant plasmid was transformed to E. coli JM 109 competent 
cells by heat-stress and extracted from bacterial colonies by colony 
PCR. The identified recombinant plasmid was then finally 
sequenced. 




The construction of vector pIN 
 
As shown in Figure 2, to produce IGF-1 insert fragment, recom-
binant plasmid pMD19-T-IGF-1 was amplified with infusion primers. 
Infusion Primers were listed in Table 1. PCR amplification was 
performed with PrimeSTAR® HS DNA polymerase. Infusion-IGF-1 
product was isolated and purified. Then we used In-Fusion™ 
Advantage PCR cloning Kit to insert infusion-IGF-1 into plasmid 
pBlue-pBC. Recombinant plasmid was named pBI. Finally, the 
digested plasmid pBI (Kpn I/ Cla I) was linked with plasmid DNA3. 
Recombinant plasmid was named pI. Then we designed a primer to 
check plasmid pI. Furthermore, to produce neo fragment, 
recombinant plasmid pMD19-T-neo was digested with restriction 
enzyme Not I. Plasmid pI was also digested with Not I. Then we 
used T4 DNA ligase to link digested plasmid pI with neo fragment. 
Recombinant plasmid was named pIN. PCR and restriction enzyme 
digestion methods were used to verify recombinant plasmid pIN. 
 
 




Bcap-37 cell line was grown in Dulbecco’s modified Eagle medium 
(DMEM) (Invitrogen, USA) supplemented with 10% fetal bovine 




Detection of the expression of IGF-1 mRNA by quantitative 
PCR  
 
Quantitative PCR assays were run to confirm whether the plasmid 
pIN could be expressed successfully in Bcap-37 cell line. Cells were 
divided into three groups 6 h after transfection: the blank group 
(normal cells), the transfection group (transfected with plasmid pIN) 
and the control group (liposome 2000). Assays were performed with 
RNA preparation from three groups. As to each group, at least 
three technical (quantitative PCR) replicates were needed. Gene-
specific primers were designed using Primer Express software. The 
primer sequences are listed in Table 2. 
 
 
Detection of the expression of IGF-1 by Western blot and 
radioimmunoassay (RIA) 
 
Bcap-37 cell line was transfected with plasmid pIN by 
liposome2000. Cells were divided into three groups 6 h after 
transfection: control group (normal cells), transfection group 
(transfected with pIN only) and transfection with induction group 
(transfected with pIN and induced with insulin, PRL and 
Hydrocortisone). The medium of control group and transfection 
group were changed into DMEM containing 10% fetal bovine 
serum. At the same time, transfection with induction group was 
added with insulin (10 µg/ml), PRL (1 µg/ml) and hydrocortisone (20 
µg/ml). Cells and medium were collected at 12, 24, 36 and 48 h for 
subsequent test. 
For Western-blot analysis, the cells were collected and dissolved 
in radioimmunoprecipitation assay (RIPA) buffer (1 mm 
phenylmethylsulfonyl fluoride (PMSF)). Supernatants were loaded 
on a 15% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) gel. Then gels were wet transferred onto 
nitrocellulose (NC) membranes. Membranes were blocked with 
Tris-buffer saline Tween20 (TBST) buffer containing 5% non-fat 
milk at room temperature for 2 h, then incubated with mouse anti- 
human IGF-1 monoclonal antibody at 4°C for 18 h and 
subsequently incubated with secondary HRP-IgG (1:10000) 
antibody at room temperature  for  2 h.  Then  IGF-1  proteins  were 




Table 1. PCR primers. 
 
Gene Sense primer  Anti-sense primer 
Product  
length (bp) 
IGF-1 ACAGGTACCATGGGAAAAATCAGCAGTCT CGCAAGCTTCTACATTCTGTAGTTCTTGT 501 
infusion IGF-1  ATCGCGGATCCTCGAGATGGGAAAAATCAG ATCGCGGATCCTCGAGATGGGAAAAATCAG 513 
neo GCGGCCGCTGTGGAATGTGTGTCAGTTA  GCGGCCGCACAGACATGATAAGATACAT 1521 
pBC1- IGF-1 TTTGCAGGATCTTGGTTC   
pBC1354 GTGAATGAGATGAAAAAGAGT TCAAAAACAAGATGTGAAATG 1354 




visualized by enhanced chemiluminescence. 
 For IGF-1 RIA, the concentration of IGF-1 in Bcap-37 cells lysate 
and cells culture medium were measured separately after 12, 24, 
36 and 48 h by a radioimmunoassay protocol. 125I-IGF-1 kit was 
purchased from Beijing Sinoukbio Company. Cells lysate and cells 
culture medium samples 0.1 ml, mixed with acid/ethanol (95% 
ethanol: 2 M HCL = 87.5:12.5) 0.4 ml, set at room temperature for 
30 min and then centrifuged at 3000 rpm / min for 30 min at 4°C. 
After centrifugation, 0.2 ml of the supernatant mixed with 0.2 ml 
0.855 M Tris solution for 30 min at 4°C, then centrifuged 3000 
rpm/min for 20 min at 4°C. Subsequently, 100 µL supernatant was 
aspired for testing. 
One hundred microliters each of cells lysate and cells culture 
medium extracts (or standards), IGF-1 anti-serum, and 125I-IGF-1 
were pipetted into duplicate RIA tubes. Tubes were vortexed and 
incubated with rotation at 4°C for 48 h. At the end of the incubation, 
500 μL of the separation reagents was added to each tube followed 
by 30 min incubation at room temperature. The tubes were then 
centrifuged at 3600 rpm, 4°C for 20 min, to separate bound 125I-
IGF-1 from unbound. Immediately after centrifugation, the 
supernatant was removed by aspiration. All RIA tubes were then 
placed in a Beckman Gamma 4000 counter, and the bound 125I-
IGF-1 fraction radioactivity was counted for 2 min per tube.  
 
 




10 healthy goats were divided into two groups: control group 
(lactating goat primed with saline) and experimental group (lactating 
goat injected with plasmid pIN). For the experimental group, 400 ng 
plasmid pIN was dissolved into saline and injected into right side 
mammary gland of each goat in day three and seven. Then 
mammary gland tissues of each group were collected to conduct 
subsequent testing in day 10. 
 
 
Detecting the expression of IGF-1 protein in goat mammary 
 
The concentration of growth hormone (GH) protein in goat 
mammary of different groups was measured by human IGF-I 
Quantikine ELISA Kit (R&D, USA). ELISA assays were performed in 
accordance with protocol.  
 
 
Transfection of the goat ear fibroblast lines and establishment 
of transgenic cell lines 
 
Purified goat ear fibroblast cells  (donated  by  shanghai  transgenic 
research) were cultured in DMEM supplemented with 10% fetal 
bovine serum, penicillin (100 U/ml), and streptomycin (100 µg/ml). 
The whole procedure was conducted according to the description 
provided with liposome 2000 regent (Invitrogen). Briefly, 1×10
5
 cells 
were seeded in each well of 6-well plate one day before 
transfection. The cells in 5 wells were transfected with 2 µg plasmid 
pIN, while one well served as control. After 48 h of transfection, 
cells were passage based on cell density at 1:3 or 1:4 into the 
appropriate medium and selected using 600 µg/ml G418 (Amresco, 
USA) for 10 to 14 days. The observed positive cell clones were 
marked with circles at the corresponding spot on the bottom of the 
culture flask or plate. Each marked circle was digested with 0.25% 
trypsin for 2 min and then transferred into 48 -well plate 
supplemented with DMEM, 10% fetal bovine serum (FBS) and 300 
µg/ml G418 until each cells in 48 wells passage into six-well plate, 
three positive clones (1, 2 and 3) were used for following analysis. 
Genomic DNA was isolated from the above three positive cell lines 
and non-transgenic cell lines with TIANamp genomic DNA Kit 
(TIANgen). Two specific primers were designed to detect the 





The statistical analyses of the concentration of IGF-1 in different 
group were carried out with SPSS 17 software. Comparison 
between two groups was carried out using t-test. A one-way 
analysis of variance (ANOVA) with Turkey’s post hoc analysis was 
performed when comparing more than two groups. Significant 
differences (P < 0.05) are noted with symbols in the Figures. All 





Cloning of igf-1 gene and neo gene 
 
Result shows that igf-1 gene was amplified and cloned 
into plasmid pMD19-T (Figure 1A). Subsequently, 
plasmid pMD19-T- igf-1 was digested with restriction 
enzyme Xho I and there were two fragments: 501 and 
2690 bp as we wished. Nucleotide sequencing showed 
100% homology to goat IGF-1 gene sequences. Results 
also show that neo gene was amplified and cloned into 
plasmid pMD19-T (Figure 1B). Then plasmid pMD19-T-
neo was digested with restriction enzyme Not I and two 
fragments, 1521 and 2690 bp, were obtained. Nucleotide 
sequencing showed 100% homology to neo gene.  






Figure 1. Construction and verification of vector pIN. (A) IGF-1 electrophoresis of PCR product (1, IGF-1; -, negative clone; +, 
positive clone; M, DNA marker / Trans2K Plus). (B) Neo electrophoresis of PCR product (1, 2, neo; -, negative clone; +, positive 
clone; M, Marker DNA /Trans2K Plus). (C) Identification of vector PI digested with restriction enzymes (Kpn I/Cla I) (1, vect or pBI-
Kpn I/Cla; 2, vector pI-Kpn I/Cla I; 3, pBC I-Kpn I/Cla I; 4, vector pI; M, marker DNA /λ-Hind III digest ). (D) Identification of vector 










Identification of recombinant plasmid PI and pIN with 
restriction enzymes 
 
Recombinant plasmid pI was cleaved with restriction 
enzymes Kpn I and Cla I (Figure 1C). Compared with 
digested plasmid pBC1 (Kpn I/ Cla I), plasmid pIN was 
identified. Furthermore, the recombinant plasmid pIN was 
cleaved with restriction enzyme Not I. Results show two 
fragments 1521 and 22108 bp as we supposed (Figure 
1D). These  results  demonstrate  that  plasmid  pIN  was  




Table 2. Quantitative PCR primers. 
 
Gene Sense primer  Anti-sense primer Product length (bp) 
IGF-1 cgtctgtgaacccggagtat gcctcgttcaccgtcttaat 193 







Detecting of the expression of plasmid pIN in Bcap-
37 cell line  
 
Detection of expression of IGF-1 mRNA by 
quantitative PCR 
 
Plasmid pIN was transfected into Bcap-37 cell line to 
evaluate its biological activity. IGF-1 mRNA was 
evaluated by quantitative PCR after 36 h. As shown in 
Figure 3A, the expression of IGF-1 in transfected group 
was greatly increased by 3000 times than that in control 
group. Results certified that plasmid pIN could be 





From Figure 3B, we observed a 7.5-kDa major band 
appearing in only a few transfected group (A8, B2 and 
B4), while most of them could not spot any band in 7.5-





Western blot analysis showed that the molecular weight 
of the expressed IGF-1 was 7.5-kDa, which was in 
agreement with the molecular weight of IGF-1 reported 
previously (Tokunou et al., 2008). Interestingly, we saw a 
17-kDa band, which was always associated with a 
smaller 7.5- kDa IGF-1 band, in the colonic specimens 





To be sure whether the expression of IGF-1 was up 
regulated in transfected cells, cells lysate and cells 
culture medium of different group were collected to 
perform RIA analysis. Results confirm that the expression 
of IGF-1 in transfection group and transfection with 
induction group was much more than that in control group 
(Figure 4). In general, the content of total IGF-1(the 
addition of IGF-1 in cells lysate and cells culture medium) 
was stably grown by time from 12 to 36 h, while the 
content of IGF-1 had a little drop down in 48 h. Compared 
with control group at 12, 24, 36 and 48 h (666.11 ± 47.78; 
730.14 ± 64.31; 776.86 ± 126.14 and 842.69 ± 89.40 
µg/L, respectively), the content of total IGF-1 in trans-
fection group (1017.40 ± 51.16; 817.90 ± 37.38; 1267.10 
± 190.51 and 1015.70 ± 61.84 µg/L) were increased 
significant in 12 and 36 h. However the expression of 
IGF-1 in transfection and induction group reached to a 
peak in 36 h (1209.60 ± 130.88, 887.65 ± 39.01, 1472.10 
± 56.47 and 1111.00 ± 86.15 µg/L) (Figure 4C). In cell 
lysate, the expression of IGF-1 in control group at 36 h 
(277.30 ± 56.19 µg/L) were precisely lower than that in 
transfection with induction group (641.13 ± 42.81 µg/L) 
(Figure 4A). Also in cell culture medium, the content of 
IGF-1 increased significant from 499.56 ± 182.28 µg/L 
(36 h, control group) to 837.33 ± 122.50 µg/L (36 h, 
transfection group) and 830.98 ± 58.32 µg/L (36 h, 
transfection with induction group) (Figure 4B). Statistical 
analysis showed that the content of IGF-1 in transfection 
and induction group was higher than that in control group 
at 24 and 48 h. The content of IGF-1 in induction group 
was significantly higher than that in control group (P 
<0.05) at 12 and 36 h. 
 
 
Detect the expression of plasmid pIN on goat 
mammary 
 
The ELISA results of goat mammary gland changed 
dramatically in different groups. In the right side (injection 
side), the IGF-1 content in injection group was 0.98 ± 
0.11 ng/mg, which was greatly higher than that in control 
group (0.72 ± 0.03 ng/mg). As to the left sides (non-
injection side), the expression of IGF-1 content dropped 
from 0.77 ± 0.11 ng/mg (injection group) to 0.66 ± 0.05 
ng/mg (control group). In general, the total IGF-1 content 
(two sides) in injection group (0.87 ± 0.07 ng/mg) was 




Detection of the established transgenic cell lines by 
PCR 
 
To clarify whether plasmid pIN was integrated into the 
genomes of transgenic cell lines, two specific primers 
were design to detect the positive clones. An amplified 
fragment for pIN included 384 bp of IGF-1 and 415 bp β-
casein 3′ region, a total of 799 bp. Result shows that 
three positive clones carried the 799 bp fragment (Figure 
6). Another amplified fragments (1354 bp) for pIN 
contained  389  bp β-casein  5′  region,  465 bp  of  IGF-1  






Figure 3. The expression of IGF-1 in Bcap-37 cell line. (A) The relative IGF-1 mRNA expression in 
Bcap-37 cell line. (B) SDS-PAGE result of IGF-1 protein in Bcap-37 cell line (A: M1, 
PageRuler™Prestained Protein Ladder; 1, control group/12 h; 2, transfection group/12 h; 3, 
transfection with induction group/12 h; 4, control group/24 h; 5, transfection group/24 h; 6, transfection 
with induction group/24 h; 7, control group /36 h; 8, transfection group/36 h; M2, protein MW marker 
(low). B: M2, Protein MW marker (low); 1, transfection with induction group /48 h; 2, transfection 
group/48 h; 3, control group /48 h; 4, transfection with induction group/36 h; 5, transfection group/36 h; 
6, control group/36 h; M1, PageRuler™Prestained Protein Ladder). (C) Western blot result of IGF-1 
protein in Bcap-37 cell line (1, control group / 24 h; 2, transfection group/24 h; 3, transfection with 
induction group/24 h; M, PageRuler™Prestained Protein Ladder; 4, control group/36 h; 5, transfection 
group/36 h; 6, transfection with induction group/36 h). IGF-1, Insulin-like growth factor 1; SDS-PAGE, 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 






Figure 4. RIA result of IGF-1 content in Bcap-37 cell line. (A) The IGF-1 content in cell lysate in different group 
at the same time (*significant difference P < 0.05). (B) The IGF-1 content in cell culture medium in different 
group at the same time. (C) The IGF-1content in cell culture medium and cell lysate of different group at the 




gene and 500 bp β-casein 3' region. Results show that 
1354 bp fragment appeared in clone lines 2 and 3, but 
not in clone line 1 for reason unknown (Figure 6). All 
these results indicate that plasmid pIN was integrated into 
the genomes of transgenic clone lines 2 and 3, but not 
clone lines 1. 
DISCUSSION 
 
IGF-1 plays an important role in mammary development 
(Loladze et al., 2006) and lactation (Hadsell et al., 2008). 
The mechanism may be that IGF-1 regulates signaling 
molecules   to  promote  AKT  activity  in  mammary  cells  










which increases the persistence of lactation (Burgos and 
Cant, (2010) or that IGF-1 could reduce the oxidative 
damage to mammary epithelial cells which in turn could 
maintain lactation. IGF-1 also blocks the apoptotic 
process of mammary epithelial cells, thus prolonging the 
lactation period and improving milk ability (Hadsell et al., 
2002). From the important role of IGF-1 in mammary 
development and lactation, what would be happened if 
IGF-1 was overexpressed? Su demonstrated that local 
over expression of IGF-1 would stimulate milk yield 
during the first lactation in transgenic mice (Su and 
Cheng, 2004). However, in transgenic swine, over-
expressed IGF-1 notably increased IGF-1 and IGFBP 
content in milk, while it had no impact on lactation 
performance (Monaco et al., 2005). Interestingly, Noble 
found an apparent discontinuity between the enhanced 
milk production in transgenic sows and the increased 
growth rate of piglets (Noble et al., 2002). Sometimes 
IGF-1 may not increase milk production, but it really 
exerted effect in another form (increasing the piglet 
growth speed). So the over expression of IGF-1 in goat 
stand a good chance for increasing milk production.  
Milk protein regulatory elements were wildly used in 
regulating lactation gene expression. Recent studies 
showed that β-lactoglobulin and β-casein obtained high 
level expression in mammary gland of rat (Lee et al., 
1996), sheep (Wright et al., 1991), goats (Parker et al., 
2004) and cows (van Berkel et al., 2002). Plasmid pBC1 
used in this experiment contained a goat β-casein 5 ' 
regulatory element which could regulate the downstream 
gene expression (Kang et al., 1998). Research on 
lactating mammary of goat, sheep and cattle found that 
αs1- and β-casein transcripts were translated three to 
four fold more efficiently than αs2- and κ-casein 
transcripts. The percentage of αs1-Cas mRNA drama-
tically dropped from 30% (αs1-CasA/A) to 3% (αs1-
CasE/F), with an intermediate value (17%) (αs1-CasA/E) 
(Bevilacqua et al., 2006). In order to verify plasmid 
bioactivity, plasmid pIN was transiently transfected into 
human breast cancer cell line Bcap-37 (Zhang et al., 
2009). Quantitative PCR results showed that pIN could 
be transcribed successfully in Bcap-37 cell line. The high 
level expression of IGF-1 mRNA in transfected group not 
only proved that β-casein 5′ regulatory element highly 
initialed the transcription, but also verified that Bcap-37 
cell line was suitable for detecting gene expression.  
In this study, Western blotting result showed that IGF-1 
were expressed at different times (12, 24, 36 and 48 h) 
and different treatments (control group, transfect group, 
transfect and inducted group), while the concentration of 
IGF-1 had no significant difference. Taking into account 
the detection limit of Western blot, we further detected the 
content of IGF-1 by RIA. RIA results showed that the 
contents of IGF-1 in cell lysate and cell culture medium 
were increased with time lasting in control group. 
However, the increment of IGF-1 was slow and low, 
which implied that Bcap-37 cells could express IGF-1 
stably at a low level. In general, the content of IGF-1 
changed greatly in other two groups at different time. At 
the beginning (12 h), transfection group and transfection 
with induction group conveyed much more IGF-1 than 
that in control group. The significant difference (P<0.05) 
between control group and transfection group convinced 
us that plasmid pIN played its role in expressing IGF-1. 
The IGF-1's increment at 12 h was primarily attributed to 
the increment in cell lysate (Figures 4A and B), which 
meant that IGF-1 was produced in cells while it did not 
secrete into cell culture medium at 12 h. As times went 
on, the IGF-1 contents in transfection and transfection 
with induction group were only slightly higher than that in 
control group at 24 h. We supposed that all plasmid pIN 
were expressed at 12 h. A part of plasmid did not 
integrate into cells, so they lost the capacity to express 
IGF-1 which resulted in the drop down of IGF-1 content in  






Figure 6. The detection of established transgenic cell lines by PCR. Lanes 1, 2 and 3, Positive transgenic cell 




24 h.  
The other hypothesis was that the transfection greatly 
harmed cells which consumed some IGF-1 to repair. Yee 
proved that IGF-1 was a potent survival factors for 
mammary epithelial cells (Yee and Wood, 2008). When 
the detection journey paused at 36 h, the content of IGF-
1 in transfection and transfection with induction group 
had a huge increase, which was significantly higher than 
that in control group at 36 h. Results in 36 h hinted us 
that plasmid pIN was stably enrolled into cell chromo-
some or cells were fully recovered from the damage 
caused by transfection. Interestingly, the expression of 
IGF-1 in 36 h reached to a peak. It was also very 
important to stress that based on our research, the 
increment of IGF-1 was primarily due to the increasing 
IGF-1 in cell culture medium which hinted that IGF-1 was 
synthesized and secreted into cell cultural medium in 36 
h. The expression of total IGF-1 showed a downward 
trend at 48 h. Surprisingly, the content of IGF-1 in cells 
cultural medium did not decrease notably, especially for 
transfection group and transfection with induction group 
which kept a high level of IGF-1 expression in 48 h. 
However in cells lysate, the content of IGF-1 declined 
notably in 48 h. This result confirms that the expressed 
IGF-1 was continuously secreted into cells cultural 
medium at 48 h. As for the reason, the depletion of 
nutrient might have led to lack of raw materials to 
synthesize IGF-1, which would result in the reduction of 
IGF-1 in cell lysate. Meanwhile, it was important to note 
that based on our analysis, obvious increase in IGF-1 
protein expression in injection side cannot be attributed 
specifically to plasmid pIN. Observations in vivo also 
found that the expression level of IGF-1 protein increased 
not only in injection sides but also in non-injection sides. 
This overall rising, whether direct, indirect, or both, would 
require a coordinated response within the mammary 
gland that involved in many different pathways.  
All RIA statistics showed that transfected cell could 
express goat IGF-1 protein and had potential to stimulate 
the increase of IGF-1 in cell level. Results also prove that 
plasmid pIN had bioactivity in efficiently expressing IGF-1 
in mammary gland cells. Previous studies had found that 
increased activity of mammary epithelial cells would lead 
to the intensifying of early lactation (Capuco et al., 2001). 
IGF-1 could not only increase the number of mammary 
epithelial cells, but also activate the secretion of 
mammary epithelial cells. Our data suggests that plasmid 
pIN had the potential to stimulate the expression of IGF-1 
in human breast cancer cell line Bcap-37, which probably 
suggested that plasmid would be effective in transgenic 
goat. Hadsell et al. (2002) proved that the sustained 
expression of IGF-1 not only blocked the apoptosis of 
mammary epithelial cells, but also slowed the aging of 
mammary cells. Results also confirm that IGF-1 could 
prolong the time of lactation and increase the milk 
secretion capacity. Our research demonstrates that 
plasmidpIN could exhibit favorable bioactivity in efficiently 
expressing IGF-1, which would be a promising way in 
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